{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:31:49Z","timestamp":1793734309309,"version":"4.6.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Weight reduction may reduce serum uric acid (SUA). This study aimed to examine the changes of SUA before and after bariatric surgery in patients with obesity with or without hyperuricaemia and gout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective analysis of 147 routinely collected data on hospital patients with obesity who underwent bariatric surgery. The body weight and SUA were measured at baseline and after surgery at 1\u20137\u2009days, 1, 3, 6 and 12\u2009months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean (95% CI) weight reduction of 147 patients was 30.7 (28.7, 32.7) kg 1\u2009year after surgery (P\u2009&amp;lt;\u20090.001). SUA decreased rapidly from 419.0 (400.1, 437.8) \u00b5mol\/l at baseline to 308.4 (289.6, 327.2) \u00b5mol\/l at 1\u20137\u2009days, flared up to 444.8 (423.9, 465.6) \u00b5mol\/l at 1\u2009month, then decreased again to 383.8 (361.5, 406.1) \u00b5mol\/l at 3\u2009months, 348.9 (326.3, 371.5) \u00b5mol\/l at 6\u2009months and 327.9 (305.3, 350.5) \u00b5mol\/l at 12\u2009months (P\u2009&amp;lt;\u20090.001). Similar trends but more rapid reductions were observed in 55 hyperuricaemia patients and 25 gout patients. All 25 gout patients had an elevated SUA above the therapeutic target (\u2265360\u00b5mmol\/l) at baseline, but in 10 patients it was reduced below this target at 12\u2009months. The mean reduction (95% CI) of SUA in all patients and gout patients was 84.3 (63.1\u2013105.4) and 163.6 (103.9, 223.3) \u00b5mmol\/l, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Bariatric surgery significantly reduces body weight and SUA for obese patients with hyperuricaemia and gout. Gout may be considered as an indicator for this surgical treatment in people with severe obesity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa822","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T21:23:08Z","timestamp":1605820988000},"source":"Crossref","is-referenced-by-count":34,"title":["Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis"],"prefix":"10.1093","author":[{"given":"Jine","family":"Lu","sequence":"first","affiliation":[{"name":"Medical Laboratory Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Bai","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Rheumatology Immunology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Medicine, Second People's Hospital, Qujing City, Yunnan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Medicine, Second People's Hospital, Qujing City, Yunnan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingcheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Dai","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, Division of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"2021010409201483200_keaa822-B1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol Biol Evol"},{"key":"2021010409201483200_keaa822-B2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1471-2458-13-664","article-title":"Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces","volume":"13","author":"Qiu","year":"2013","journal-title":"BMC Public Health"},{"key":"2021010409201483200_keaa822-B3","first-page":"2602","volume-title":"Practice of internal medicine","author":"Chen","year":"2013","edition":"14th edn"},{"key":"2021010409201483200_keaa822-B4","first-page":"89","article-title":"Research progress on the pathogenesis and drug treatment of gout","volume":"20","author":"Yang","year":"2014","journal-title":"Guiding J Tradit Chin Med Pharm"},{"key":"2021010409201483200_keaa822-B5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"2021010409201483200_keaa822-B6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B7","first-page":"438","article-title":"Interpretation of the Chinese guideline for the management of gout in 2010","volume":"32","author":"Zeng","year":"2012","journal-title":"Chin J Pract Int Med"},{"key":"2021010409201483200_keaa822-B8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"2021010409201483200_keaa822-B11","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2021010409201483200_keaa822-B12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"2021010409201483200_keaa822-B13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-7075-1-10","article-title":"Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle","volume":"1","author":"Hayden","year":"2004","journal-title":"Nutr Metab (Lond)"},{"key":"2021010409201483200_keaa822-B14","first-page":"711","article-title":"Expert consensus on prevention and treatment of adult obesity in China","volume":"27","author":"Obesity Group of Endocrinology Branch of Chinese Medical Association","year":"2011","journal-title":"Chin J Endocrinol Meta"},{"key":"2021010409201483200_keaa822-B15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1253\/circj.69.928","article-title":"Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome","volume":"69","author":"Yoo","year":"2005","journal-title":"Circ J"},{"key":"2021010409201483200_keaa822-B16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-5996-4-3","article-title":"The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus","volume":"4","author":"Kim","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"2021010409201483200_keaa822-B17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(72)92271-4","article-title":"Effect of weight-loss on plasma and urinary levels of uric acid","volume":"300","author":"Nicholls","year":"1972","journal-title":"Lancet"},{"key":"2021010409201483200_keaa822-B18","first-page":"255","article-title":"Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet","volume":"10","author":"Yamashita","year":"1986","journal-title":"Int J Obes"},{"key":"2021010409201483200_keaa822-B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1463-1326.2002.00181.x","article-title":"Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity","volume":"4","author":"Gokcel","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"2021010409201483200_keaa822-B20","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/annrheumdis-2017-211472","article-title":"Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal observational studies","volume":"76","author":"Nielsen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11695-012-0610-7","article-title":"IFSO-APC consensus statements 2011","volume":"22","author":"Kasama","year":"2012","journal-title":"Obes Surg"},{"key":"2021010409201483200_keaa822-B23","volume-title":"The surgery of obesity and metabolic diseases","author":"Wang","year":"2014"},{"key":"2021010409201483200_keaa822-B24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/annrheumdis-2013-203970","article-title":"Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study","volume":"73","author":"Dalbeth","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021010409201483200_keaa822-B25","first-page":"13","article-title":"The evaluation of laparoscopic sleeve gastrectomy for morbid obesity and the international expert panel consensus statement","volume":"33","author":"Tang","year":"2013","journal-title":"Chinese J Pract Surg"},{"key":"2021010409201483200_keaa822-B26","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"2021010409201483200_keaa822-B27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","article-title":"Inflammation: a possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease","volume":"31","author":"Perez-Ruiz","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"2021010409201483200_keaa822-B28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"2021010409201483200_keaa822-B29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021010409201483200_keaa822-B30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCGENETICS.114.000556","article-title":"Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels","volume":"7","author":"Rasheed","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2021010409201483200_keaa822-B31","first-page":"1188","article-title":"Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients","volume":"82","author":"Tinahones","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2021010409201483200_keaa822-B32","first-page":"418","article-title":"North China bariatric & metabolic surgery clinical database registry report (2019)","volume":"40","author":"Li","year":"2020","journal-title":"Chin Practical Surg Mag"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa822\/35384681\/keaa822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa822\/35384681\/keaa822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T16:34:09Z","timestamp":1609778049000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article\/doi\/10.1093\/rheumatology\/keaa822\/6062103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa822","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"article-number":"keaa822"}}